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Recent advances in the implementation and understand-
ing of three-dimensional (3D) contrast magnetic reso-
nance angiography (MRA) are making vascular imag-
ing throughout the body safer and more accurate. This
article is intended to describe the basic principles behind
3D contrast MRA and demonstrate how to apply this
technique to multiple vascular territories with emphasis
on abdominal applications. The inherent advantages of
3D contrast MRA over ‘‘conventional’’ MRA tech-
niques such as time of flight (TOF) and phase contrast
(PC) are discussed. In addition, techniques for improved
spatial and temporal resolution, decreased respiratory
motion artifacts, decreased contrast dosing, and more
accurate bolus timing are explored.
Conventional MRA
Magnetic resonance pulse sequences can exploit blood
motion to visualize vascular structures directly without
the use of intravascular contrast material. In 2D or 3D
TOF angiography, which is usually performed using a
flow compensated gradient refocused sequence, station-
ary tissues are ‘‘saturated’’ and thus have low signal
intensity [1–3]. Blood upstream of the imaging volume,
however, is ‘‘unsaturated.’’ When this blood flows into
the imaging volume, it is bright compared with the sta-
tionary background tissues. This ‘‘inflow’’ or TOF ap-
proach often works well, especially in normal arteries
and veins, including the extremities, carotid arteries, and
cerebral vasculature [4–13]. It also has the benefit of
allowing selective saturation of blood adjacent to the
imaging volume such that either arterial or venous sig-
nal can be suppressed. One major disadvantage of TOF
angiography is inplane saturation, which can be a prob-
lem with slowly flowing and tortuous arteries or when
the long axis of the vessel coincides with the scan plane.
A second drawback is turbulence-induced signal loss in
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a region of stenosis [14, 15]. In addition, imaging times
tend to be long, in part because it is often necessary to
image perpendicular to the vessel axis to avoid inplane
saturation.
PC angiography uses phase shifts as blood flows in
the presence of ‘‘flow-encoding’’ gradients [1, 16, 17].
Using phase difference images, signal phase intensity is
proportional to velocity, and stationary background tis-
sue is suppressed. The flow encoding gradients can be
applied in any or multiple directions depending on the
desired flow sensitivity. PC angiography can be imple-
mented as a 2D or 3D gradient refocused sequence. It
has proved useful for evaluation of the renal arteries,
carotids, and portal vein [8, 12, 17–21]. In normal ves-
sels without stenoses or turbulence, the results are often
spectacular.
Another strength of PC angiography is its ability to
measure flow velocities. In combination with CINE and
cardiac gating, a time-resolved velocity profile can be
generated that is quite similar to an ultrasound Doppler
waveform [22, 23]. This profile provides physiologic
flow data and allows the quantitative measurement of
flow rates. Unfortunately, it is this same velocity sen-
sitivity that limits PC angiography. Strong flow encod-
ing gradients make the sequence susceptible to degra-
dation from bulk (cardiac, respiratory, translational)
motion. In addition, PC sequences are only sensitive to
a specified range of velocities [20]. In occlusive disease,
turbulence causes a broad spectrum of rapidly changing
velocities, which in turn causes intravoxel phase dis-
persion and signal loss. Thus, artifactual loss of vessel
visualization at a stenosis is common [14]. Interestingly,
this apparent deficiency can be useful for identifying
regions of turbulent, disordered flow when used in con-
junction with 3D contrast MRA.
Contrast-enhanced MRA: theory
Three-dimensional contrast-enhanced MRA is performed in a manner
analogous to conventional contrast angiography. Instead of relying on
blood motion to create intravascular signal, a contrast agent (gadolin-
ium chelate) is introduced to change the T1 (spin lattice) relaxation
of blood such that it is very different from surrounding tissues. Blood
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can then be directly imaged irrespective of flow, which alleviates
many of the problems inherent to TOF and PC angiography. In par-
ticular, sensitivity to turbulence is dramatically reduced, and inplane
saturation effects are eliminated [14, 15]. The technique allows a small
number of slices oriented in the plane of the vessels of interest to
image an extensive region of vascular anatomy (equal to the field of
view) in a short period of time. Thus, 3D contrast MRA is intrinsically
fast, with high-quality breath-hold angiograms being possible when
using modern MR units.
Gadolinium chelates
Gadolinium (Gd3/) is a paramagnetic metal ion that decreases both
the spin–lattice (T1) and spin–spin (T2) relaxation times [24]. Be-
cause Gd3/ itself is biologically toxic, it is chelated with ligands such
as DTPA (gadopentetate dimeglumine) to form small-molecular-
weight contrast agents [25]. These ‘‘extracellular’’ agents diffuse from
the intravascular compartment into the interstitial space in a matter of
minutes, meaning selective imaging of the vascular structures must be
performed rapidly [14, 25]. As compared with iodinated contrast
agents, gadolinium chelates have a very low rate of adverse events
and no nephrotoxicity, a significant advantage when evaluating pa-
tients with impaired renal function [26–30]. Gadolinium chelates de-
crease the T1 of blood according to the equation [15, 31].
1/T1 Å 1/1200 / R [Gd] (1)1
where R1 is the field-dependent T1 relaxivity of the gadolinium chelate
(approximately 4.5 s01·mmol01 at 1.5 T), [Gd] is the concentration of
gadolinium chelate, and 1200 (ms) is the T1 of blood without gado-
linium (at 1.5 T). A similar equation exists for T2 (which is always
shorter than T1).
‘‘Blood pool’’ agents
Because of the rapid redistribution of gadolinium chelates into the
extracellular compartment, some investigators have suggested using
intravascular paramagnetic contrast agents rather than ‘‘extracellular’’
gadolinium chelates for 3D contrast MRA. These agents include high-
molecular-weight polychelates such as albumin-(Gd-DTPA)x, poly-
lysine-(Gd-DTPA)x, dextran-(Gd-DTPA)x, and superparamagnetic
iron oxides [32–38]. The potential advantages of these agents include
a long intravascular half-life with minimal leakage into the interstitial
space and significantly higher relaxivities (R1), allowing decreased
molar dosing.
To date, with the exception of a couple of human MRA studies
using superparamagnetic iron oxides, most of the investigation has
been in animals, with much work aimed at evaluating relative tissue
blood volume, estimating perfusion, and evaluating capillary integrity
[37, 39–43]. It is not yet known whether these blood pool agents will
have any advantage over extracellular agents for dynamic arterial-
phase MRA. There are also concerns regarding the safety profiles of
some of these agents [44–46]. Although MR angiography using blood
pool agents may ultimately be useful, current clinical work uses ex-
tracellular gadolinium chelates.
Pulse sequence
Gadolinium-enhanced MRA (Gd-MRA) exploits the transient short-
ening in blood T1 following intravenous administration of gadolinium
chelates using a fast 3D spoiled gradient echo (SPGR) sequence [15,
47, 48]. We use the term ‘‘transient’’ because this technique exploits
the ‘‘first pass’’ of gadolinium and because studies have indicated that
80% of the administered gadolinium dose disappears from the intra-
vascular space within 5 min [49]. With this technique, typical repe-
tition times (TR) are less than 10 ms, with echo times (TE) of 1–3
ms and total scan times in the 20–45-s range. This type of sequence
is ideally suited to MRA because it has high spatial resolution and an
intrinsically high SNR, it is fast (it can be performed in a breath-hold),
and it can be oriented and reformatted in any desired plane [13, 50–
54]. In addition, because intravascular signal is dependent on T1 re-
laxation rather than on inflow or phase accumulation, inplane satura-
tion and turbulence induced signal loss are not a problem [15]. The relative
signal intensity (SI) for a 3D SPGR acquisition can be written as [55]
0TR/T1 0TR/T1 0TE/T2*SI Å [N(H)(1 0 e )/(1 0 cos (a)e )] sin (a)e (2)
where N(H), TR, TE, and a are the proton density, repetition time,
echo time, and flip angle, respectively. Examining equation 2, SI is
maximized if either TR is very long or T1 is very short because as
(TR/T1) becomes large, e0TR/T1 approaches zero. Of these options,
lengthening TR is not desirable because it increases scan time. This
leaves shortening T1 as the primary method for increasing intravas-
cular signal intensity. Figure 1 shows an example of relative signal
intensity versus flip angle a for different T1 values (assuming a TR
of 7 ms with TE ! T2*). Note the significant increase in signal in-
tensity as T1 approaches zero.
Gadolinium dose and T1
For blood to appear bright with respect to the background tissues,
sufficient gadolinium must be administered to reduce the blood T1
below the T1 of the brightest background tissue, i.e., fat, which has a
T1 of approximately 270 ms. Ignoring gadolinium recirculation and
assuming that the blood compartment constitutes 8% of body mass
and the extracellular fluid compartment is 30% of body mass, the
equilibrium T1 of blood can be calculated from equation 1 for a given
dose of gadolinium, both before and after redistribution into the ex-
tracellular compartment [14] (Fig. 2).
Based on Figure 2, doses of greater than approximately 0.1 and
0.2 mmol/kg are required to decrease the blood T1 to below that of
fat for blood pool and redistribution phases respectively, but Gd-MRA
is typically performed dynamically rather than at equilibrium. This
method has the advantage of eliminating steady-state background sig-
nal but at the same time is essentially a ‘‘one-shot’’ technique, mean-
ing that once gadolinium is given and dynamic imaging performed,
the process cannot be repeated until gadolinium is cleared from the
soft tissues, a period of many hours considering the biologic half-life
of approximately 90 min [56]. Hence, timing is extremely important
in dynamic Gd-MRA. To appreciate timing issues, the relationship
between injection rate, blood T1, and resultant signal intensity must
be understood.
For times shorter than the recirculation time, gadolinium concentration
of the bolus in blood can be approximated from equation 3 [14, 15]:
(rate of Gd injection in mol/L)
[Gd] Å (3)
(cardiac output in L/s)
Combining equations 1 and 3 and assuming no recirculation, blood
T1 can be calculated for a given cardiac output and injection rate,
which is demonstrated in Figure 3 for cardiac outputs of 3, 5, and 7
L/min using a standard gadolinium chelate preparation with a con-
centration of 0.5 mol/L.
Note from Figure 3 that for a ‘‘typical’’ cardiac output of 5 L/min,
an injection rate of 1 cc/s yields a blood T1 of 36 ms, whereas a 2 cc/
s injection produces a blood T1 of 18 ms. These T1 values are much
shorter than the T1 values of fat. Of course, such a fast injection cannot
and need not be sustained for the full imaging time. For a typical 70-kg
patient receiving a ‘‘double dose’’ (0.2 mmol/kg) of gadolinium, this
amounts to 28 cc of a 0.5 mol/L gadolinium chelate preparation. Thus,
a 1 cc/s injection can be sustained for 28 s, or a 2 cc/s injection sus-
tained for 14 s. Even though the imaging time may be longer than the
injection time, by properly timing the bolus with respect to image
acquisition, full advantage of the dynamic blood T1 shortening can
be obtained because of the unique way in which MR data are acquired.
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Fig. 1. Relative signal intensity for different T1 values versus flip an-
gle a for an SPGR sequence. TR Å 7 ms, TE ! T2*.
Fig. 2. Blood T1 versus gadolinium dose. Initial distribution (blood
pool) and delayed phases.
Fig. 3. Blood T1 versus injection rate for changing cardiac outputs
(CO), assuming no recirculation.
Fig. 4. Relative signal intensity versus gadolinium injection rate for an
SPGR sequence. Flip angle a Å 557, cardiac output Å 5 L/min.
Fig. 5. Relative signal intensity in the aorta and inferior vena cava
(IVC) versus time following a 0.1-mmol/kg gadopentatate dimeglu-
mine injection of 10 s duration. Keyhole SPGR technique. Adapted
from the work of Strouse et al. [67].
Fourier (k-space) considerations
MR imaging does not map spatial data linearly with respect to time.
With 3D MR imaging, the entire 3D ‘‘Fourier’’ or ‘‘k-space’’ data set
is collected before individual slices are reconstructed. Because k-space
maps spatial frequencies rather than spatial data itself, the k-space data
do not directly correspond to image space. Instead, different parts of
k-space data determine different image features. For example, the cen-
ter of k-space, or ‘‘low’’ spatial frequencies, dominate image contrast,
whereas the periphery of k-space, or ‘‘high’’ spatial frequencies, con-
tribute more to fine details such as edges [57, 58], which means that
the state of the intravascular T1 in large vessels is essentially ‘‘cap-
tured’’ at the time corresponding to acquisition of central k-space [57].
If central k-space is collected when arterial [Gd] is high but gadolin-
ium has not yet reached the venous structures (arterial phase), only
the arteries will be bright. The fact that intravascular gadolinium con-
centration may not be uniform over the entire acquisition time may
generate artifacts, but these are relatively minor provided that [Gd] is
not rapidly changing over the critical central portion of k-space [57].
Thus, with proper timing, gadolinium injection duration need not be
as long as the entire acquisition time. For a given gadolinium dose,
the injection strategy then becomes a trade off between a fast injection
(shorter T1, more intravascular signal) and long injection (more uni-
form T1, fewer artifacts).
Another factor to be considered is phase-encoding order. Tradi-
tionally, phase encoding is performed ‘‘sequentially’’ such that central
k-space is acquired at the mid-point of the scan. Alternatively, phase
encoding can be performed in a ‘‘centric’’ fashion such that central
k-space is acquired at the beginning of the scan [59, 60]. Although
centric phase encoding order can be somewhat more prone to artifacts
if [Gd] is rapidly changing during central k-space acquisition, it
greatly simplifies bolus timing and is less susceptible to incomplete
breath-holds [57, 61, 62].
Contrast material injection rate
For injection rates greater than approximately 2 cc/s (Fig. 3), there is
diminishing return with respect to T1 shortening. But even small de-
creases in T1 lead to tremendous increases in signal intensity (Fig. 1).
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Fig. 6. MIP images from coronal 3D gadolinium-enhanced MRAs of
the abdominal aorta in the same patient. A Optimal bolus timing for
arterial phase. B Acquisition of central k-space too early, with resul-
tant ‘‘ringing’’ artifact. C Delayed arteriovenous phase. Note the sur-
gically created portal vein to the left renal vein shunt (arrow).
Combining equations 1–3 and assuming TE ! T2*, signal intensity
versus injection rate can be plotted for a fixed cardiac output and flip
angle (5 L/min and 557 in this example; (Fig. 4). This graph demon-
strates that signal intensity increases asymptotically as injection rate
increases, with only minimal increases seen beyond a rate of 4–5 cc/s.
Different investigators have taken different approaches to optimizing
injection rate. Before the advent of high-speed gradient systems, which
permitted total acquisition times of less than 1 min (in the realm of a
breath-hold), imaging times were on the order of 3–5 min, and injections
were typically performed so that a ‘‘double dose’’ (0.2 mmol/kg) was
administered at a uniform rate over the entire scan duration [47, 63]. For
a 4-min scan on a 70-kg patient, this amounted to an injection rate of just
over 0.1 cc/s. Many investigators now use a ‘‘double dose’’ (0.2 mmol/
kg) of gadolinium chelate with injection rates of 1–2 cc/s, whereas some
use up to a ‘‘quadruple dose’’ (0.4 mmol/kg) and rates of 4–5 cc/s [13,
52, 54, 64, 65]. We personally feel that ‘‘double dose’’ with an injection
rate of about 2 cc/s is a good compromise between maximal arterial signal
and minimal artifacts for breath-hold scans [66].
Contrast-enhanced MRA: bolus timing
considerations
The timing of the gadolinium bolus acquisition of central k-space is ex-
tremely important. The contrast travel time, defined as the time required
for contrast to travel from the injection site to the vascular territory of
interest, is highly variable. Some idea of contrast travel times and arterial/
venous enhancement profiles can be gained by examining the work of
Strouse et al., who evaluated signal change in the aorta and IVC based
on rapid time resolved 3D SPGR ‘‘keyhole’’ imaging [67]. An example
of this is shown in Figure 5, where data are averaged from four patients
receiving a 0.1 mmol/kg bolus of gadopentatate dimeglumine over 10 s
(approximately 1.5 cc/s bolus, beginning at time t Å 0).
First note that arterial signal (proportional to [Gd]) peaks rather
sharply, with an approximately 8–10-s delay before subsequent ve-
nous enhancement. (If the bolus were of longer duration, i.e., larger
total dose, the arterial peak would be somewhat broader.) This obser-
vation has important implications. Because intravascular signal inten-
sity is determined by the gadolinium concentration at the time the
center of k-space is collected [57], whether central k-space is acquired
at time t1 , t2 , or t3 (see Figure 5) has a dramatic influence over the
resultant image. Perfect timing (t2) yields maximum arterial signal
with minimal venous signal (Fig. 6A). If, however, central k-space
data are acquired too early (t1 ; while arterial [Gd] is still rapidly in-
creasing), severe ‘‘ringing’’ or ‘‘banding’’ artifacts can be generated
(Fig. 6B) [57]. These artifacts also are referred to as ‘‘leading edge’’
artifacts because they result from imaging during the leading edge of
bolus arrival. Acquiring central k-space data too late (t3) leads to sub-
maximal arterial signal intensity and associated venous enhancement.
These two factors can be detrimental to evaluation of the arterial struc-
tures. An example of such delayed timing is shown in Figure 6C.
Hence, if one knows or can predict or measure the time course of
intravascular [Gd], the placement of central k-space can be tailored to
achieve the desired image characteristics, be it maximum arterial sig-
nal, maximum portal venous signal, etc.
‘‘Best-guess’’ technique
Several solutions to proper bolus timing have been offered. Perhaps
the simplest is to just make an educated ‘‘best guess.’’ The best guess
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involves estimating the contrast travel time from the site of injection
to the vascular structure of interest. Although this time is highly vari-
able (in a study of 50 patients, mean time between the initiation of
gadolinium injection and arrival in the abdominal aorta was 23 { 5
s, with a range of 13–37 s), an experienced MR angiographer can
reliably achieve good results by taking factors such as injection site,
patients age, cardiac output, and vascular anatomy into consideration
[69]. Using this technique with a sequential phase encoding order,
timing can be calculated as follows [52]:
imaging delay Å (estimated contrast travel time)
/ (injection time/2) 0 (imaging time/2) (4)
where imaging delay is the delay between initiating the bolus and
starting the scan (if negative, it refers to the delay between initiating
the scan and starting the bolus). Equation 4 times things such that the
midpoint of the bolus arrives at the desired vascular territory at the
midpoint (central k-space) of the scan. As an example, for a scan time
of 30 s with an estimated contrast travel time of 20 s and a 28-cc
gadolinium bolus at 2 cc/s (double dose for a 70-kg patient with a 14-
s injection), the imaging delay would be 12 s (i.e., start the scan 12 s
after beginning the injection). Of course this times the bolus such that
the midpoint arrives as central k-space is collected, meaning that, de-
pending on injection duration, there could already be venous enhance-
ment by the time central k-space is collected. In this case, one may
want to subtract a couple of seconds from the imaging delay time.
The most difficult aspect of the best guess technique is estimating
the contrast travel time. As previously alluded to, it is better to image
slightly late (increased venous phase) than slightly early (ringing/
banding artifact; Fig. 6B). With this in mind, as a general guideline
for travel time from an antecubital vein to the abdominal aorta, we
start with approximately 15 s for a young healthy patient. A young
hypertensive or athletic patient would need fewer seconds. A healthy
elderly patient would need approximately 20–25 s. Patients with car-
diac disease or an aortic aneurysm would be in the 25–35-s range.
Severe cardiac failure in conjunction with aortic pathology might be
up to 40–50 s. We add 3–4 extra seconds if the intravenous line is
in the hand.
Test bolus technique
A better, although somewhat more laborious way to estimate contrast
travel time is through use of a test bolus [69, 70]. With this technique,
1–2 cc of gadolinium (followed by 10–15-cc saline flush) are injected
at the same rate as that planned for the actual injection. Multiple sin-
gle-slice fast gradient echo images of the appropriate vascular region
are then obtained as rapidly as possible (at least every 1–2 s) for
approximately 1 min. The time of peak arterial enhancement (contrast
travel time) is then determined visually or by using region-of-interest
analysis. Timing is then determined from equation 4. To minimize
time of flight effects, the 2D test bolus image should be either oriented
along the vessel of interest (i.e., sagittal or coronal for the aorta) or
relatively thick (ú1 cm).
Using the test bolus technique for abdominal aortic imaging, Earls
et al. demonstrated a mean aortic SNR increase of 902% (15 patients)
following a 1 ml bolus of gadopentetate dimeglumine [69]. By util-
izing the resultant contrast travel time (24.0{ 12.6 s), they were 100%
successful in obtaining a ‘‘pure’’ arterial phase study (as compared
with 80% with best-guess timing) and saw significantly increased aor-
tic SNR (29.8 vs. 20.5).
There are three main drawbacks to the test bolus technique. First,
setting up, performing, and analyzing the test bolus lengthens the
overall examination time. In the hands of Earls et al., the average time
penalty was less than 5 min [69]. Second, the test bolus will rapidly
redistribute into the interstitial space, thereby increasing background
signal. For such small test doses, however, these effects are negligible.
Finally, there is no absolute guarantee that the imaging bolus will
behave identical to the test bolus because of moment-to-moment pa-
tient variables such as venous return and cardiac output and the dif-
ferent total volume of injection.
Automated bolus detection
An automated (and hence simpler) yet somewhat more sophisticated
approach for assuring proper bolus timing involves directly monitor-
ing a vascular structure for arrival of contrast material and then ‘‘trig-
gering’’ a centric acquisition once contrast arrival is detected (MR
Smartprep, GE Medical Systems, Milwaukee, WI) [68, 71]. In this
technique, signal from a large (approximately 10 1 4 1 4 cm) ‘‘mon-
itor’’ voxel overlapping the appropriate vascular structure (user de-
fined, e.g., abdominal aorta) is rapidly obtained by using a simple spin
echo sequence (time resolutionÇ20 ms). Initially, the sequence gath-
ers approximately 20 s worth of data from the monitor voxel and
calculates a baseline signal intensity and standard deviation. The se-
quence then continues to collect monitor data as contrast material is
injected. Signal intensity is compared with the baseline in real time,
and when it exceeds one or a combination of thresholds (typically a
signal increase of greater than 15–20% and 3–4 SD above the mean),
the sequence ‘‘triggers,’’ meaning that it first pauses (user defined,
typically 4–5 s) to allow intravascular [Gd] to peak and breath-hold-
ing to initiate, then collects centric 3D SPGR data. This method en-
sures that peak arterial [Gd] and central k-space occur simultaneously.
Applying this automated technique to 50 consecutive patients un-
dergoing abdominal MRA, Prince et al. found that for the same dose,
arterial enhancement was 47% greater and inferior vena cava enhance-
ment 57% less using the trigger when compared with 15 patients un-
dergoing the best-guess technique (both values statistically signifi-
cant) [68]. Alternatively, they found comparable aortic enhancement
to best-guess timing by using 30% less gadolinium. Although they
did have a 19% trigger ‘‘failure rate,’’ this rate was mainly due to
hardware/software problems in the early prototype sequence, which
have been resolved.
The main pitfalls of this technique are improper placement of the
tracker volume and patient movement such that the tracker volume is
no longer aligned with the appropriate vascular structure. A user-de-
fined default time is set to the maximum anticipated contrast travel
time so that in the event of a trigger failure, a ‘‘salvage’’ study is
obtained with delayed, but hopefully still diagnostic, bolus timing.
MR fluoroscopy
Another method of properly timing the contrast bolus still under de-
velopment at this time makes use of extremely rapid ‘‘fluoroscopic’’
MR imaging [58, 72]. With this technique, a parallel array processor
is employed to reconstruct rapidly the sagittal 2D gradient refocused
images through the vascular structure of interest. In this fashion, im-
ages are generated in near real time and updated approximately once
per second. The operator can watch the contrast bolus arrive and then
switch over to a centric 3D imaging sequence when the desired en-
hancement is detected. Alternatively, automatic computer analysis can
be performed, and the sequence can ‘‘trigger’’ in a fashion similar to
the automated bolus detection.
This technique has the advantage of allowing real-time operator-
dependent decision making, which may be particularly advantageous
in the evaluation of cases with unusual or asymmetric flow patterns,
for optimizing venous signal, or in circumstances where it is difficult
to choose a location for conventional triggering. As an example, en-
hancement downstream of a high-grade stenosis or complete vessel
occlusion may be delayed compared with the normal side or may fill
in later from collateral flow. Because such abnormalities may not be
recognized beforehand, automated triggering may not provide optimal
images. The ability to assess the vasculature ‘‘on the fly’’ under these
circumstances could improve image quality. Although no commer-
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cially available MR scanners have this capability at present, adding
the necessary hardware and software should not be problematic.
Temporally resolved 3D contrast MRA
Because proper bolus timing is so difficult and a timing mistake can
ruin the study, some investigators have advocated ‘‘temporally’’ re-
solved techniques whereby multiple 3D datasets are acquired (or syn-
thesized) extremely rapidly (every 2–8 s) [73–75]. With such tech-
niques, bolus timing is no longer a factor because multiple vascular
phases are obtained without any predetermined timing (i.e., inject and
begin scanning simultaneously). The operator simply selects the de-
sired image set, be it pure arterial, maximum venous, etc., which is
particularly useful in the carotid arteries, where the venous phase is
extremely rapid, and in the case of vessels with variable rate filling,
as may occur with stenoses, occlusions, or AV fistulas [73].
Levy and Maki used a commercial imaging system to implement
a ‘‘streamlined’’ 3D SPGR sequence that collected 12 slices with a
temporal resolution of 7 s [73]. Using this system, they were able to
differentiate reliably the arterial, early arteriovenous, late arteriove-
nous, and ‘‘washout’’ arteriovenous phases in the carotid arteries. As
compared with standard breath-hold 3D MRA, their images suffered
a considerable loss in volume coverage and SNR due to the small
number of slices and partial Fourier techniques employed. Nonethe-
less, image quality was quite acceptable provided adequate vascular
territory could be covered with the available number of slices.
Higher spatial resolution and increased volume coverage can be
obtained by using the 3D TRICKS (time-resolved imaging of contrast
kinetics) sequence [74, 75]. In this technique, k-space is divided into
four blocks. The central block of k-space (which contributes most to
image content) is repeatedly collected every 2–8 s in an alternating
fashion with the other three blocks of more peripheral k-space. Images
are then ‘‘synthesized’’ at 2–8-s temporal resolution by piecing to-
gether each unique central block of k-space with a linear interpolation
of the remaining k-space blocks acquired in closest temporal prox-
imity.
This technique works well and allows greater temporal and spatial
resolution/volume coverage than that obtained with a streamlined con-
ventional sequence. The technique also lends itself to ‘‘video’’ format,
where passage of contrast material can be viewed directly. The biggest
drawback is the large amount of processing time required to perform
the multiple reconstructions, which are currently done off-line. Also,
k-space discontinuities, in conjunction with changing intravascular
gadolinium concentration, can potentially lead to artifacts. These ar-
tifacts, however, are small provided the gadolinium bolus is not too
compact [76].
Contrast-enhanced MRA: logistical considerations
The following logistical considerations apply to 3D contrast MRA in
general, whether using best-guess timing, a test bolus, or triggering.
Artifacts
Related to k-space
The key to maximizing arterial enhancement is to image such that the
center of k-space is collected when arterial gadolinium concentration
[Gd] is at a maximum. Acquiring central k-space data after arterial
[Gd] has peaked leads to suboptimal arterial signal and increased ve-
nous signal (Figs. 5, 6C). Acquiring central k-space during the rapid
upslope in arterial [Gd] causes ‘‘ringing’’-type leading edge artifacts
(Fig. 6B). Even with optimal timing, similar artifacts can be generated
with the use of very compact boluses such that [Gd] falls rapidly while
still acquiring relatively central k-space [76]. These artifacts are not
as severe if k-space is mapped in a sequential rather than a centric
manner [57].
Thus, when using best-guess timing, sequential phase encoding is
more forgiving. Also, our group tends to overestimate slightly the
contrast travel time so that (inevitable) timing errors are more likely
to cause increased venous enhancement than ringing artifacts. When
using the test bolus technique with known contrast travel time, either
centric or sequential phase encoding can be used. The advantage to
centric encoding is twofold: less degradation with an incomplete
breath-hold (see Respiratory section) and simplified operator logistics
with respect to timing (no need to count backward to the middle of
the scan to figure out when to inject; just inject, wait the proper delay,
initiate breath-hold, and start imaging). For automated bolus detection
(or fluoroscopic techniques), centric phase encoding is typically used.
Because [Gd] rise times are not instantaneous, the delay from trigger
to initiation of data acquisition becomes crucial to avoid artifacts. If
the 3D MRA triggers at time t1 , the appropriate delay is (t2 0 t1) (Fig.
5). This delay, of course, differs by patient and vascular territory. With
trigger thresholds of 15–20% and 3–4 SD above the mean, a delay
of 4–5 s worked well for abdominal aortic imaging [68]. In patients
expected to have particularly slow flow (CHF, aneurysm), this time
should be lengthened to 6–7 s. In the carotids, however, which have
a more rapid upslope, trigger delays of 2–3 s are more appropriate to
avoid jugular venous enhancement (work in progress).
Respiratory
Respiratory motion causes ghosting, blurring, and signal loss [77, 78].
In 3D imaging, blurring occurs in the direction of the motion, whereas
ghosting is most pronounced in the slow phase encoding direction.
Before the advent of fast imaging systems, 3D contrast MRA acqui-
sition times were on the order of 3 min, making breath-holding an
impossibility. Thus, early contrast MRA images suffered from signif-
icant image degradation, particularly when evaluating small vessels
such as renal arteries [15]. Figure 7A,B illustrates the difference be-
tween breath-holding and free breathing.
Recently, many investigators have demonstrated the beneficial ef-
fects of breath-holding on 3D contrast MRA [13, 52–54, 62]. Holland
et al. evaluated the same six patients using both breath-hold and non-
breath-hold 3D contrast MRA [13]. They found that the non-breath-
hold studies failed to identify three of four peripheral renal artery
abnormalities, missed one of two accessory renal arteries, and were
unable to visualize any of the renal artery bifurcations at the hilum.
In contrast, breath-hold 3D contrast MRA identified all abnormalities,
all accessory renal arteries, and renal artery bifurcations at the hilum
in all patients.
Maki et al. looked at SNR loss and blur associated with incomplete
breath-holds [62]. Their work demonstrated that breath-holding during
the acquisition of the central 50% of k-space was the most important
for minimizing blur. Thus, for centric phase encoding, the majority of
the benefit from breath-holding can be obtained even if the patient
begins breathing at the midpoint of the scan. Data from a study by
Wilman et al. shows that the more fully ‘‘centric’’ the phase encoding
order is, the fewer the artifacts from partial breath-holds [61]. These
data suggest that, for centric phase encoding orders, an optimistic
assessment of a patient’s breath-hold ability is in order because there
is little to lose if they ‘‘don’t quite make it.’’
Now that breath-hold 3D contrast MRA is a practical reality on
most updated MR systems, breath-holding should be performed when-
ever possible. We have found that patients are better able to breath-
hold if someone explains the procedure and expectations well in ad-
vance of the actual scan. We find that the vast majority of ambulatory
patients can breath-hold for at least 30 s, and many have endurance
well beyond this. Although performing a test breath-hold before the
scan is always a possibility, watching a patient’s respiratory pattern
often provides a clue to the breath-hold potential. In our experience,
patients who take slow deep breaths with relatively long expiratory
pauses have no problem completing a 30–40-s breath-hold. Patients
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Fig. 7. MIP images from abdominal 3D gadolinium-enhanced MRAs
(different patients). A Breath holding. B free breathing. Note the sig-
nificant improvement in visualization of the distal renal arteries with
breath holding. Patient in A is shown after abdominal aortic aneurysm
repair (from [62], with permission).
who breath rapidly with no pause between expiration and subsequent
inspiration often have trouble with a breath-hold of this duration. Sick
or postoperative inpatients often cannot or will not hold their breath
at all.
We recommend the following breathing strategy. For best-guess
or test dose bolus timing techniques, pre-breath the patient for three
or four cycles (‘‘deep breath in . . . and breath out . . .’’) so that the
last inspiration is held (‘‘deep breath in and hold . . .’’) as the scan
starts. Some investigators have advocated the use of supplemental
oxygen during this pre-breathing [52]. For automated bolus detection
or fluoroscopy techniques, breath the patient for three or four cycles
and then have them relax and start the sequence to collect baseline
data and wait for bolus arrival. Once the sequence triggers, use some
prearranged signal such as tapping the arm to initiate a breath-hold.
This signal needs to occur during the ‘‘delay’’ time, so that the patient
is motionless once actual data collection starts.
Determining imaging time
The duration of a 3D contrast MRA acquisition (ts) depends on several
variables and can be written as
t Å YRES*ZRES*TR (5)s
where YRES and ZRES are the number of phase encoding steps in y
and z, and TR is the repetition time. TR is itself a function of echo
time (TE), echo type (i.e., full or fractional), and bandwidth. Spatial
resolution is determined by voxel size, which is determined by
voxel size Å (y FOV/YRES) 1 (z FOV/ZRES)
1 (x FOV/XRES) (6)
where x, y, and z FOV refer to the x, y, and z fields of view, and
XRES is the number of data points digitized during readout. These
parameters must be juggled to achieve the necessary volume coverage,
spatial resolution, and SNR while keeping the scan time ts within the
anticipated breath-hold duration tb (or to at least no more than twice
the breath-hold duration, per the argument of Maki et al. [62]). Thus,
there are multiple trade-offs. Increasing resolution (YRES or ZRES
with same overall slab thickness), increasing volume coverage (ZRES
with same slice thickness), or increasing SNR (decreasing bandwidth
or changing from fractional to full echo), increases scan time (ts). A
mathematical analysis specific to breath-hold Gd-MRA for optimizing
SNR by considering these variables is underway.
One method sometimes employed to reduce scan time without a
loss in resolution is to use an asymmetric FOV (i.e., decrease both y
FOV and YRES symmetrically). This method decreases scan time
(while preserving resolution) at the expense of a smaller y FOV, which
can be useful, particularly with large FOV studies where structures at
the periphery of the y FOV are not important and wrap around (alias-
ing) is not an issue. Another useful technique without an associated
time penalty is to zero-fill k-space in the slice direction [79]. A 21
zero-fill yields twice the number of slices. Although the slice thickness
is unchanged, the slices now overlap by one half a slice thickness.
Although this technique does not actually increase resolution, it pro-
vides for smoother reformats by reducing partial volume effects.
Thus, the art of 3D breath-hold contrast MRA boils down to a
careful choice of the parameters in equations 5–6 and is often an
iterative process. As a rule, we start from the maximum estimated
breath-hold duration (tb) and desired slice thickness. We then increase
ZRES to cover the required volume. If an asymmetric FOV can be
used, we do so. We then increase YRES until tb is reached (minimal
value of 128). If ts cannot be made less than tb after this manipulation,
then sacrifices must be made. Partial Fourier techniques can be used
(i.e., collect only a certain fraction of y phase encodes) at the cost of
decreased SNR. Alternatively, bandwidth can be increased, also at the
cost of decreased SNR. Slice thickness can be increased at the cost of
decreased spatial resolution. Finally, incomplete breath-holding can
be anticipated at the cost of increased ghosting and blurring.
In cases where breath-holding is not as important, such as in the
extremities or perhaps the carotids, there is more flexibility in choos-
ing imaging parameters. In these circumstances, the limiting factor
becomes contrast bolus duration. A ‘‘compact’’ bolus (with respect to
imaging duration) causes distortion in a similar fashion to the ringing
artifacts that occur when central k-space is acquired during the leading
edge of intravascular [Gd]. Thus, assuming a double dose (0.2 mmol/
kg) of a gadolinium chelate (0.5 mol/L) for a 70-kg patient adminis-
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tered at 2 cc/s, the injection duration is only 14 s. Assuming the bolus
will broaden by several seconds before reaching the target vessels,
this broadening is still less than approximately 20 s. To avoid artifacts,
this needs to be a substantial fraction of the scan time ts , and scan
times much greater than approximately 60 s are probably counterpro-
ductive. Nonetheless, this increase in imaging time allows for in-
creased SNR and spatial resolution. When considering carotids, the
rapidity of venous return also must be considered. This rapidity limits
scan duration because the longer the scan, the closer the proximity of
phase encoding to central k-space when venous signal arrives, which
leads to greater venous signal and leading-edge venous artifact. We
suspect carotid imaging durations of much greater than 30 s will sig-
nificantly degrade image quality. As Wilman and Riederer pointed
out, however, the more truly ‘‘centric’’ the phase encoding, the less
degradation there will be from a compact bolus [60].
Patient preparation
The more relaxed and informed a patient is, the more easily that pa-
tient can remain still and perform a long breath-hold. Therefore, re-
assurance and a brief description of the scan can really help. In patients
who are particularly anxious, premedication with sedatives such as
diazepam may be useful. Premedication helps the patient to relax and
lie still and also decreases cardiac output [14]. This latter effect helps
enhance image quality because arterial phase [Gd] increases with de-
creasing cardiac output (equation 3, Fig. 3).
Because most 3D contrast MRA is performed in the coronal plane,
arm position is important to allow for a smaller FOV without aliasing.
For carotid, large FOV aortic, or runoff studies, the arms can remain
by the patient’s side because aliasing is not a factor. For pulmonary,
small FOV aortic, renal, and mesenteric studies, the arms must be
either elevated out of the imaging plane using cushions or extended
over the head [52]. Both of these positions in which the arms are
elevated have the added benefit of gravity-aided venous return.
We recommend placing the intravenous device before the patient
is in the magnet. This procedure alleviates anxiety and possible shifts
in patient position that may occur if the device is placed just before
contrast injection. If the MRA will be performed with the arms by the
patient’s side, placing the intravenous device in the antecubital vein
is adequate. If the arms will be over the head, it is preferable to place
the device below the antecubital fossa so it will not kink and obstruct
should the patient’s elbow bend. A 22-gauge catheter is usually ade-
quate and, if injecting by hand, will provide enough resistance that
excessively rapid injections are not made. With gadolinium prepara-
tions such as gadopentetate dimeglumine (Magnevist, Berlex Labo-
ratories, Wayne, NJ), however, warming to body temperature is re-
quired to decrease the viscosity enough to allow for adequate injection
rates through a 22-gauge intravenous device.
Gadolinium injection
The total gadolinium dose and rate of delivery are trade-offs between
maximizing intravascular signal and minimizing artifacts. In the ideal
situation, a large dose at a high rate would be optimal, but this, how-
ever, must be weighed against safety, practicality, and cost. We feel
that for breath-hold contrast MRA with accurate bolus timing (test
bolus technique, automated detection, fluoroscopy), a double dose (0.2
mmol/kg) administered at a rate of approximately 2 cc/s represents a
good balance between these factors. In practice, however, once a bottle
(20 mL) of gadolinium is opened, it is best to inject the entire bottle.
Hence, we round the dose up to the next higher number of bottles,
which generally amounts to two bottles (40 mL). For best-guess-type
techniques, we prefer 0.3 mmol/kg at the same approximate rate.
These recommendations can, under certain circumstances, be modi-
fied. For example, in a particularly small patient in whom the volume
of a double dose is small, artifact from a compact bolus may be gen-
erated. To remedy this result, either the injection rate can be decreased
(thereby lengthening the bolus at the expense of intravascular signal)
or the dose can be increased (at the expense of increased cost). If cost
is an overwhelming concern, the dose and injection rate can be de-
creased at the expense of intravascular signal, or the dose alone can
be decreased at the expense of compact bolus artifact.
In experienced hands, we find that manual injection works quite
well. Because many institutions do not have a power injector, manual
injection often is the only choice. Manual injections are also simpler
in some ways because there is less ‘‘plumbing’’ and less opportunity
for mechanical difficulties. That said, a power injector (e.g., Spectris
MR Injector, MedRad, Pittsburgh, PA) offers a more constant and
standardized bolus delivery. Either way, the contrast injection itself
must be followed rapidly by adequate saline flush to complete delivery
of the bolus and help flush the arm veins. Suggested flush volumes
range from 15 to 50 cc [52, 69], with most investigators using 15–20
cc. The rate of flush is usually the same as the gadolinium bolus itself.
For hand injections, a standardized tubing set that allows rapid switch-
over between gadolinium and saline injection works best (Smartset,
TopSpins, Plymouth, MI). Most power injectors automatically follow
gadolinium delivery with a user-defined saline bolus, which eliminates
possible delays in ‘‘switchover’’ with manual injection.
Imaging different vascular phases
With most 3D contrast MRA studies, extensive efforts are made to
image the arterial phase optimally, as has been extensively discussed.
Once the arterial phase dataset is collected, however, the sequence can
(and should) be repeated to obtain venous and equilibrium phases.
Later phases are useful in evaluating portal venous or venous struc-
tures, parenchymal enhancement patterns, and perhaps even renal glo-
merular function [80]. Temporal resolution is determined by a com-
bination of scan time and the time required for the patient to prepare
for another breath-hold. Aside from techniques such as 3D TRICKS,
the faster the scan, the better the potential temporal resolution [75].
In cases where high temporal resolution is desired (such as perhaps in
the carotids or in cases of AV shunts), the previously described
streamlined techniques can be used in a single breath-hold, although
SNR and spatial resolution decrease [73]. In more ‘‘conventional’’
breath-hold 3D contrast MRA, with a scan time ofÇ30 s, we advocate
giving the patient approximately 10–15 s to ‘‘catch their breath’’ and
then scan again. In this manner, the second ‘‘arteriovenous’’ phase
occurs approximately 40–45 s after peak arterial phase. This is usually
well timed for the portal venous phase and often adequate for evalu-
ating venous structures and parenchymal phases in the visceral organs
(Fig. 6C). Sometimes a third run may be desired, usually to evaluate
slow venous return or the renal collecting system.
Because these ‘‘later’’ phase examinations occur more in the equi-
librium phase of gadolinium distribution, intravascular T1 is increased
(Fig. 2), and therefore signal is reduced as compared with arterial
phase (Fig. 6A,C). To maximize signal in these later phases, the flip
angle should, if possible, be reduced (see Fig. 1). We feel that whereas
the optimum flip angle for arterial phase is 45–557, the optimal flip
angle decreases to 20–307 in later phases.
Postprocessing and display
Three-dimensional Gd-MRA produces a contiguous volume of image
data. For a typical body MRA study, this volume is asymmetric, being
perhaps 32 1 32 1 6.4 cm. For a representative acquisition matrix
size of 256 1 160 1 32, this volume produces voxels 1.25 1 2.0 1
2.0 mm in size. For diagnostic purposes, this dataset is best viewed
interactively using a computer workstation allowing for thin multi-
planer reformatting [1, 81]. In this manner, thin (1.25–2.0 mm in this
case) slices can be viewed in axial, sagittal, coronal, or oblique planes,
thus eliminating overlapping structures and unfolding tortuous ves-
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Fig. 8. Coronal 3D gadolinium-enhanced MRA of the tho-
racic aorta. A Full-thickness coronal MIP. B Thin axial re-
format through the aortic arch demonstrating a type I aortic
dissection. C Parasagittal oblique subvolume MIP (taken
from B) demonstrating the extent of the dissection. Matrix
Å 256 1 160 1 48, zero-filled to 96 in slice, 3/4 NEX,
FOV Å 48 cm, slice thickness Å 3.2 mm, TR Å 6.1, TE Å
1.2, scan time Å 43 s, bandwidth Å 31.2 kHz, flip angle Å
457.
sels. Because these reformatted slices remain thin and are not projec-
tions, they not only provide the best achievable contrast but also min-
imize the chance of diagnostic error when used diligently (see Fig.
8B) [1, 81].
Because thin reformations show only short vascular segments, it
is advantageous to utilize the maximum intensity projection (MIP)
postprocessing technique [82, 83]. Using this algorithm, the user first
specifies the subvolume thickness and desired viewing plane. The al-
gorithm then generates rays perpendicular to the viewing plane, takes
the maximum value of any voxel encountered along that ray, and
assigns that maximum value to the corresponding pixel in the output
image. This technique is fast and works extremely well with tech-
niques such as Gd-MRA because vascular signal is typically much
greater than background signal. It provides projection images that are
quite similar to conventional angiograms in appearance. The MIP al-
gorithm is demonstrated in Figure 8, which shows a full thickness
coronal MIP of the thoracic aorta (Fig. 8A), a thin slice axial refor-
mation through the superior aspect of the aortic arch (Fig. 8B), and
an oblique subvolume MIP taken from the axial reformat demonstrat-
ing the origins of the great vessels and an extensive type I aortic
dissection (Fig. 8C). As can be seen, this technique is very helpful for
displaying complex vascular anatomy, particularly when vessels are
not oriented along a single plane.
Despite its usefulness, the MIP algorithm is subject to artifacts.
Perhaps the most common artifact arises when stationary tissue has
greater signal intensity than the vascular structures, as can occur in
the presence of fat, hemorrhage, metallic susceptibility artifacts, or
motion artifacts. This in turn leads to the mapping of nonvascular
signal to the projection image and causes a discontinuity in vessel
signal, potentially mimicking stenosis or occlusion [1]. This type of
artifact is best overcome by minimizing the thickness of the MIP sub-
volume, thereby excluding as much extraneous data as possible. Other
artifacts inherent to the MIP technique have been described [84]. Such
artifacts mainly consist of underestimating vessel lumen and are more
of a problem with TOF or PC techniques. Because of these potential
pitfalls, most investigators agree that the MIP images should be used
as a roadmap and use the source images for definitive diagnosis [1,
81, 84].
Subtraction techniques are also useful in image evaluation, partic-
ularly in vascular regions not subjected to significant respiratory mo-
tion. These areas include the extremities, pelvis, and carotids. A ‘‘dig-
ital subtraction’’ MRA can be accomplished most easily by
subtracting pre- from postcontrast magnitude (reconstructed) images.
Provided the patient maintains the same position on both studies, sub-
traction will eliminate background signal and improve vessel conspi-
cuity. This technique has been used successfully in the extremities
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Fig. 9. Coronal (A) and sagittal (B) MIP reformats
from a 3D gadolinium-enhanced MRA of the ab-
dominal aorta demonstrating a large infrarenal sac-
cular aneurysm. The renal, celiac, superior mesen-
teric, and iliac arteries are normal. Automated bo-
lus detection with breath-hold. Matrix Å 256 1
160 1 48, FOV Å 32 cm, slice thickness Å 2.7
mm, TR Å 6.5, TE Å 1.8, scan time Å 51 s, band-
width Å 31.3 kHz, flip angle Å 457.
[85, 86]. An improvement on this technique involves complex sub-
traction of the pre- and postcontrast ‘‘raw’’ (k-space) datasets, which
overcomes phase differences in voxels that contain both stationary
and moving spins (i.e., very small vessels), allowing for increased
vascular signal [87].
Contrast-enhanced MRA: clinical applications in the
abdomen
This section reviews techniques and imaging parameters
for gadolinium-enhanced MRA in the abdomen. The pa-
rameters provided here were derived from clinical ex-
perience with the Horizon 1.5-T system (GE Medical
Systems, Milwaukee, WI) using software version 5.5 or
5.6 with echo planer capable gradients (SR110) and the
body coil. The general techniques described in the pres-
ent section are applicable to other systems and vascular
territories, although the parameters may need to be ex-
trapolated as appropriate.
Based on the previous discussion, several general
principles apply when performing Gd-MRA. First, TR
and TE need to be as short as possible without exces-
sively increasing the bandwidth. Echo time (TE) can be
minimized by using a fractional (asymmetric) echo. For
the Horizon system using a bandwidth of {32 kHz,
minimum TR/TEs of approximately 6.0–7.0/1.2–2.0
ms are possible. Other systems are capable of an even
shorter TR. Second, slice thickness should be no greater
than 2.0–2.6 mm, unless imaging large structures where
fine detail is not of great concern (such as the portal
vein), in which case slice thicknesses of up to 3.0–3.5
mm are often acceptable. Third, in cases where breath-
holding will be performed (advantageous everywhere,
essential in the abdomen), the number of slices and
phase encoding steps must be balanced among adequate
volume coverage, adequate resolution, and constrained
breath-holding time. For a typical FOV of 32 cm, 128
phase encodings (the minimum number usually used)
corresponds to a resolution of 2.5 mm. For 128 phase
encodings and a TR of 7 ms, approximately 44 slices
can be obtained in a 40-s breath-hold or 22 slices in a
20-s breath-hold. These imaging times can be reduced
further by using partial Fourier imaging (1/2 NEX). Fi-
nally, for most arterial phase studies, it is best to use an
automated bolus detection technique, which is particu-
larly true for renal and carotid studies, where too much
imaging delay causes interference due to adjacent ve-
nous opacification. If automated bolus detection is not
available, a test bolus can be used. If neither of these
techniques are feasible, best-guess timing can be un-
dertaken.
Abdominal aorta
Three-dimensional gadolinium-enhanced MRA of the
abdominal aorta is performed most often to evaluate dis-
section (Fig. 8) or aneurysmal disease (Fig. 9). The Gd-
MRA sequence is typically performed in a coronal plane
(so that the iliac and renal vessels also can be evaluated)
and is prescribed from a 2D ‘‘black blood’’ gradient
refocused breath-hold sagittal localizer. Prescribing
from a breath-hold localizer serves several purposes.
First, it is fast. Second, it captures the anatomy in the
same breath-hold position in which the Gd-MRA will
performed, thus decreasing the chances of having a vital
structure (such as the anterior aspect of an aneurysm)
fall outside the FOV. Finally, it gives the patient a
chance to practice a breath-hold when the outcome is
not crucial.
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Fig. 10. Coronal MIP from a 3D gadolinium-enhanced MRA of the renal arteries
(A) and corresponding axial 3D phase contrast (PC) angiogram (B). The right re-
nal artery is normal. The gadolinium MRA study demonstrates severe stenosis of
the proximal left renal artery, with delayed enhancement of the left renal paren-
chyma. On the 3D PC study, there is complete loss of left renal artery signal,
signifying significantly decreased flow in the left renal artery. Manual bolus tim-
ing with breath-hold. Matrix Å 256 1 128 1 32, FOV Å 32 cm, slice thickness
Å 2.0 mm, TR Å 14.1, TE Å 2.6, scan time Å 58 s, bandwidth Å 16 kHz, flip
angle Å 457.
Fig. 11. Sagittal oblique MIP from a 3D gadolinium-enhanced MRA of a renal
transplant patient demonstrating a widely patent transplant renal artery arising
from the left external iliac artery. Manual bolus timing without breath-hold. Ma-
trix Å 256 1 128 1 64, FOV Å 32 cm, slice thickness Å 1.5 mm, TR Å 14.4,
TE Å 2.7, scan time Å 1 min 59 s, bandwidth Å 16 kHz, flip angle Å 457.
A 32-cm FOV is usually adequate for Gd-MRA of
the abdominal aorta. If the patient is very large or has
iliac/thoracic aortic disease, the FOV can be increased
as needed. As the FOV increases, however, resolution
decreases, and evaluating the renal arteries becomes
more difficult. Slice thickness and number of slices are
chosen based on desired resolution and breath-holding
capability. Ideally, slice thickness should be Ç2.5 mm
or less. For very large aneurysms, however, it may be
necessary to increase slice thickness to 3.0–3.5 mm.
Because large aneurysms have slow, swirling flow,
extra time is required for the aneurysm to opacify maxi-
mally. When using automated bolus detection, we find that
a 5-s delay is optimal for a nondiseased aorta and that 7 s
are more appropriate for patients with the exceedingly
slow flow associated with a large aortic aneurysm or con-
gestive heart failure. Extremely large aneurysms also may
require a larger gadolinium dose; we often use three bottles
(60 mL) under these circumstances.
Another factor worth considering when using au-
tomated bolus detection is monitor volume placement
because many aneurysms (or false lumens in the case
of dissection) are partially thrombosed. Thrombus often
can be hard to distinguish from the sagittal localizer.
Axial T1 or T2 images can help in localizing the patent
portion of the lumen.
Renal arteries
Gadolinium-enhanced MRA of the renal arteries is per-
formed similarly to the abdominal aortic study, except the
FOV is kept to a maximum of 32 cm (minimum deter-
mined by patient size to avoid aliasing). Typically, 32
slices are obtained with a slice thickness no greater than
Ç2.6 mm. This thickness allows for high resolution with
relatively short scan times (õ30 s). Breath-holding is ex-
tremely critical because distal branches and accessory re-
nal arteries are difficult to evaluate in the presence of re-
spiratory motion. If the patient is a good breath-holder,
resolution can be increased by decreasing slice thickness
and increasing the number of phase encoding steps.
Figure 10A shows a severe proximal left renal artery
stenosis. Three-dimensional PC imaging (Fig. 10B) can
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Fig. 12. Coronal (A), sagittal (B), and axial (C) MIP im-
ages from a 3D gadolinium-enhanced MRA of mesen-
teric arteries demonstrates a replaced right hepatic artery
arising from the superior mesenteric artery (arrow). Note
also the excellent definition of the common hepatic (h),
left hepatic (lh), gastroduodenal (gd), and inferior mes-
enteric (im) arteries. The proximal SMA and celiac are
normal. Automated bolus detection with breath-hold.
Matrix Å 256 1 128 1 32, FOV Å 36 cm, slice thick-
ness Å 3.5 mm, TR Å 6.7, TE Å 1.8, scan time Å 28 s,
bandwidth Å 31.2 kHz, flip angle Å 457.
be a useful adjunct in the evaluation of renal artery ste-
nosis. The Gd-MRA images demonstrate the anatomy,
and the PC images show signal drop-out in regions of
turbulence or extremely slow flow, which indicates the
stenosis is hemodynamically significant [88].
Transplant renal arteries also can be evaluated (Fig.
11) [89]. Because these arteries are in the pelvis, respi-
ratory motion is not as pronounced, and breath-holding
is not as critical. Nonetheless, it is best to have the pa-
tient breath-hold if possible. Although coronal imaging
with a 32-cm FOV is usually adequate, sagittal imaging
can be performed with a smaller FOV. This technique
provides higher resolution but covers much less vas-
cular territory. Transplant renal veins are easily seen on
the venous phase of the study.
Mesenteric arteries
The mesenteric vessels are included on renal or abdom-
inal aortic Gd-MRA studies (Fig. 12). The proximal ce-
liac and superior mesenteric arteries are usually well
visualized, even in the presence of respiratory motion.
The inferior mesenteric artery is often seen.
Dedicated mesenteric artery studies are performed
in the coronal plane. Slice thickness must be minimized
(õ2.6 mm) because the proximal mesenteric arteries
travel primarily in the slice direction (note the somewhat
‘‘jagged’’ appearance of the 3.5-mm slices shown in
Fig. 12B). Zero-filling in the slice direction helps to
smooth out the sagittal reconstructions. Keep in mind
that the hepatic, gastroduodenal, and distal superior
mesenteric arteries may be farther anterior than is usu-
ally included in a renal study, and therefore volume cov-
erage will need to be increased (or shifted anteriorly) to
see these structures.
Portal/hepatic veins
Portal venous or hepatic vein studies are performed in
a coronal plane (Figs. 13, 14). Slice thickness is gen-
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Fig. 13. Coronal MIP images from 3D gadolinium-enhanced MRA of
the portal vein in two different patients after liver transplant. A Severe
stenosis of the main portal vein (arrow) at the site of the anastamosis.
The superior mesenteric and splenic veins are patent. Matrix Å 256
1 128 1 32, FOV Å 36 cm, slice thickness Å 3.0 mm, TR Å 6.7, TE
Å 1.8, scan time Å 28 s, bandwidth Å 32 kHz, flip angle Å 457. B
Dilated gastroesophageal varices (arrow). Note also the mild stricture
of the infrahepatic IVC related to transplant surgery (arrowhead).
Matrix Å 256 1 128 1 32 zero filled to 64 in slice, 3/4 NEX, FOV
Å 48 cm, slice thickness Å 2.8 mm, TR Å 7.0, TE Å 2.1, scan time
Å 18 s, bandwidth Å 32 kHz, flip angle Å 457. Both studies were
obtained in the portal venous phase (approximately 60 s postinjection)
with breath-hold.
Fig. 14. Coronal (A) and oblique (B) MIP images from 3D gadolin-
ium-enhanced MRA of the portal vein in a patient with severe portal
hypertension after liver transplant. This case demonstrates a large in-
ferior mesenteric venous collateral decompressing the portal system
into the IVC, which is focally aneurysmal. Matrix Å 256 1 128
1 32, FOV Å 36 cm, slice thickness Å 4.0 mm, TR Å 5.1, TE Å 1.2,
scan time Å 21 s, bandwidth Å 31.2 kHz, flip angle Å 457. The study
was obtained in the portal venous phase (approximately 60 s postin-
jection) with breath-holding.
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erally increased to 3.0–4.0 mm to adequately cover the
relevant portal venous structures. An axial study is use-
ful in determining the anterior and posterior extents of
the portal/hepatic veins.
In portal venous/hepatic venous studies, timing is
not as crucial as with arterial studies because the portal
venous phase is longer and thus easier to isolate. After
obtaining the arterial phase images, an approximately
5–10-s pause allows the patient to recover from the
breath-hold. Imaging is then repeated, followed by a
second pause and a third scan. In this manner, the sec-
ond set of images usually provides a nice portal venous
and hepatic venous phase. The third set may show col-
laterals to better advantage, if they exist.
This protocol has the added advantage of being es-
sentially a dynamic liver study. Hence, if there is con-
cern over a hepatic mass, this mass can be evaluated
dynamically, provided it is included in the imaging vol-
ume. Under these circumstances, further delayed phases
should be obtained for 10–15 min.
Summary
Gadolinium-enhanced MRA in the abdomen provides a
safe, fast, and cost-efficient alternative to conventional
diagnostic angiography. Numerous recent advances al-
low for high-resolution breath-hold imaging with opti-
mal arterial-phase gadolinium bolus timing. As the tech-
nique is refined further, greater spatial and temporal
resolution will become possible, thus increasing the use-
fulness of Gd-MRA.
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